Verition Fund Management LLC Invests $1.51 Million in GP-Act III Acquisition Corp. (NASDAQ:GPAT)

Verition Fund Management LLC bought a new stake in shares of GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report) during the 3rd quarter, according to its most recent filing with the SEC. The firm bought 149,437 shares of the company’s stock, valued at approximately $1,506,000.

Several other hedge funds have also modified their holdings of the stock. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in GP-Act III Acquisition in the third quarter valued at approximately $13,099,000. Periscope Capital Inc. acquired a new stake in GP-Act III Acquisition during the 3rd quarter valued at $2,772,000. PNC Financial Services Group Inc. purchased a new stake in GP-Act III Acquisition during the 3rd quarter worth $1,613,000. Wolverine Asset Management LLC acquired a new position in GP-Act III Acquisition in the 3rd quarter worth $2,894,000. Finally, Dakota Wealth Management purchased a new position in GP-Act III Acquisition in the 3rd quarter valued at about $488,000.

GP-Act III Acquisition Stock Performance

Shares of NASDAQ GPAT opened at $10.13 on Friday. GP-Act III Acquisition Corp. has a 1 year low of $9.98 and a 1 year high of $10.15. The stock’s 50-day simple moving average is $10.09.

GP-Act III Acquisition Profile

(Free Report)

We are a blank check company incorporated as a Cayman Islands exempted company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.

Further Reading

Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report).

Institutional Ownership by Quarter for GP-Act III Acquisition (NASDAQ:GPAT)

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.